Pharmacokinetics and plasma-concentration-effect relationships of prenalterol in cardiac failure
Authors:
- D. FitzpatrickDFD. Fitzpatrick
- 1 January 1985
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 28 (4) , 397-403
Abstract
Prenalterol was administered as an intravenous infusion at three incremental rates (60, 120 and 240 nmol/min) to five patients with severe cardiac failure. Haemodynamic, hormonal and metabolic variables were measured at the same time as plasma prenalterol concentrations, and the pharmacokinetics of the drug were studied by following plasma concentrations and urinary excretion during and after the infusion. Concentration-dependent increases in cardiac index, stroke index and stroke work index were observed without increases in arterial pressure, heart rate or myocardial oxygen demand. The reninangiotensin-aldosterone system was stimulated, although the extent of stimulation varied among patients. No strong correlations were found between the logarithm of the plasma prenalterol concentration and effect. Plasma clearance of the drug was lower in cardiac patients than in normal volunteers, but a large decrease in renal clearance was partially balanced by an increase in nonrenal clearance. Over the observed range of concentrations, no deviation from linearity was evident, and plasma concentrations of about 150 nmol/l were effective in improving cardiac function without significant side-effects.Keywords
This publication has 29 references indexed in Scilit:
- Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure.Circulation, 1983
- Hemodynamic influences upon the variance of disposition residence time distribution of drugsJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failureActa Medica Scandinavica, 1982
- Hemodynamic effects of intravenous prenalterol in severe heart failureThe American Journal of Cardiology, 1981
- Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary diseaseAmerican Heart Journal, 1981
- Hemodynamic and Cardiometabolic Effects of Prenalterol in Patients with Gram Negative Septic ShockActa Anaesthesiologica Scandinavica, 1980
- Role of β-1 and β-2 adrenoceptors in isoproterenol-induced renin release in conscious dogsLife Sciences, 1979
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation, 1978
- Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFITJournal of Pharmacokinetics and Biopharmaceutics, 1977
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977